Francisco Partners has agreed to acquire Weave, a health technology company, in a deal valued at $650 million. The transaction will take Weave private, marking a significant move for the company and its investors. The announcement was made this week, highlighting Francisco Partners’ continued interest in the health tech sector.
The acquisition process involved negotiations between Francisco Partners and Weave’s existing shareholders. The private equity firm will purchase all outstanding shares of Weave, with the deal expected to close in the near term pending regulatory approvals. Francisco Partners has a history of investing in technology-driven healthcare companies, positioning it well to support Weave’s growth plans.
This deal underscores the ongoing consolidation in the health technology market, where private equity firms are actively acquiring companies with strong digital health offerings. Comparable transactions in the sector have attracted attention for their size and strategic value, reflecting the increasing demand for integrated communication and management solutions in healthcare. The $650 million valuation places Weave among notable recent health tech buyouts.
The completion of the acquisition will enable Weave to focus on expanding its product offerings and customer base without the pressures of public market scrutiny. Francisco Partners’ investment aims to accelerate Weave’s innovation in healthcare communication technologies. The deal’s closure date has not been disclosed but is anticipated within the current quarter.